ArticleFrontiers in surgery2026
Case Report: Giant communicating solitary fibrous tumor of the temporal skull base and infratemporal fossa.
Article in Frontiers in surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Solitary fibrous tumor (SFT) is a rare mesenchymal spindle-cell neoplasm that can arise in the central nervous system and the head and neck region. Giant communicating lesions spanning the temporal skull base and infratemporal fossa are exceptionally uncommon and remain diagnostically and surgically challenging. Case presentation: We report a 76-year-old man who presented with more than 3 years of intermittent headache and dizziness, recent symptom progression, and a palpable right maxillofacial mass. Magnetic resonance imaging demonstrated a strongly enhancing right temporal skull base lesion extending through the foramen ovale into the infratemporal/masticator space, measuring approximately 74 × 61 mm. Preoperative MR angiography did not show an obvious close relationship between the tumor and adjacent major vessels. After multidisciplinary evaluation, the patient underwent combined craniofacial tumor resection and skull base reconstruction performed jointly by neurosurgery and oral and maxillofacial surgery. Histopathology showed a spindle-cell neoplasm with alternating cellularity and staghorn-like vessels, 1-2 mitotic figures per 10 high-power fields, no necrosis, and no marked cytologic atypia. Immunohistochemistry showed nuclear STAT6 positivity together with CD34, CD99, and Bcl-2 expression and a Ki-67 labeling index of approximately 5%, supporting the diagnosis of central nervous system World Health Organization grade 1 SFT. The postoperative course was uneventful, symptoms improved, and no recurrence was reported on outside follow-up magnetic resonance imaging at 22 months. Conclusion: This case adds to the limited literature on skull base SFT with intracranial-extracranial extension and highlights the importance of careful clinicoradiological assessment, multidisciplinary maximal safe resection, pathological confirmation with STAT6, and sustained radiological surveillance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.